股號 / 名稱 | 營收 | 稅後淨利 |
6469 大樹 | 133,161,332.15 | 5,132,262.33 |
4104 佳醫 | 63,214,073.29 | 6,879,005.93 |
4175 杏一 | 58,634,454.73 | 623,435.72 |
5288 豐祥-KY | 53,273,331.2 | 5,088,792.52 |
6491 晶碩 | 50,930,596.81 | 13,631,286.29 |
6288 聯嘉 | 43,119,046.72 | 32,356.77 |
1565 精華 | 37,578,303.22 | 6,029,871.01 |
4116 明基醫 | 37,298,266.75 | 1,887,191.62 |
8403 盛弘 | 35,296,997.57 | 40,154.32 |
4129 聯合 | 34,709,418.31 | 4,272,137.16 |
3218 大學光 | 33,142,171.89 | 7,495,872.05 |
4745 合富-KY | 31,860,088.67 | -71,528.72 |
6782 視陽 | 31,839,458.93 | 6,093,417.98 |
5312 寶島科 | 31,093,503.42 | 4,592,573.54 |
4121 優盛 | 29,894,276.86 | -721,488.39 |
4164 承業醫 | 29,564,538.68 | 2,802,022.44 |
4720 德淵 | 28,744,966.92 | 1,343,389.16 |
9919 康那香 | 25,054,023.62 | -3,618,002.42 |
4771 望隼 | 22,792,334.65 | 4,828,035.03 |
5284 jpp-KY | 18,892,361.72 | 725,018.78 |
4163 鐿鈦 | 18,081,661.97 | 1,312,997.13 |
4126 太醫 | 17,778,785.43 | 4,063,383.82 |
4107 邦特 | 16,986,167.41 | 4,415,286.7 |
1733 五鼎 | 15,642,993.14 | 1,016,690.18 |
4737 華廣 | 14,989,472.38 | -1,636,994.6 |
4155 訊映 | 14,068,501.75 | -681,426.17 |
4728 雙美 | 14,046,122.17 | 5,268,228.29 |
8109 博大 | 11,759,781.88 | 3,713,752.67 |
4138 曜亞 | 10,940,332.91 | 1,727,495.31 |
1593 祺驊 | 8,916,070.16 | 980,373.24 |
6569 醫揚 | 8,718,767.56 | 821,628.6 |
6612 奈米醫材 | 7,888,205.54 | 774,935.39 |
6747 亨泰光 | 7,044,596.45 | 1,551,804.81 |
1786 科妍 | 6,821,414.56 | 1,755,185.83 |
4161 聿新科 | 6,451,061.57 | 544,355.04 |
1783 和康生 | 5,339,818.41 | 1,520,276.92 |
6762 達亞 | 5,084,617.45 | 144,162.6 |
6499 益安 | 3,217,042.51 | -6,187,479.78 |
4183 福永生技 | 3,157,087.32 | 197,763.09 |
6661 威健生技 | 2,777,279.03 | 227,817.43 |
6767 台微醫 | 2,760,885.75 | -296,552.54 |
4198 欣大健康 | 2,546,729.38 | -432,702.7 |
6598 ABC-KY | 2,300,799.53 | -2,358,575.08 |
5398 慕康生醫 | 2,096,129.15 | 82,211.98 |
4171 瑞基 | 1,917,460.85 | -863,993.25 |
6130 上亞科技 | 1,711,470.42 | -61,121.75 |
8409 商之器 | 1,480,214.7 | -273,436.18 |
6733 博晟生醫 | 1,358,554.48 | -1,072,593.09 |
6649 台生材 | 843,977.49 | -35,426.67 |
4188 安克 | 322,861.6 | -599,122.09 |
載入數據中...